IDR 210.0
(0.96%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -36.13 Billion IDR | 41.35% |
2022 | -60.59 Billion IDR | -529.79% |
2021 | 14.09 Billion IDR | 188.88% |
2020 | -15.86 Billion IDR | -282.86% |
2019 | 8.67 Billion IDR | 349.18% |
2018 | -3.48 Billion IDR | -510.79% |
2017 | 847.43 Million IDR | 584.25% |
2016 | -175 Million IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | -12.26 Billion IDR | -64.12% |
2024 Q1 | -3.65 Billion IDR | 5.62% |
2024 Q2 | -7.47 Billion IDR | -104.42% |
2023 Q4 | -3.87 Billion IDR | 90.03% |
2023 FY | -35.53 Billion IDR | 41.35% |
2023 Q3 | -38.83 Billion IDR | -296.24% |
2023 Q2 | 19.78 Billion IDR | 256.79% |
2023 Q1 | -12.62 Billion IDR | 20.98% |
2022 FY | -60.59 Billion IDR | -529.79% |
2022 Q3 | -14.64 Billion IDR | 21.72% |
2022 Q2 | -18.71 Billion IDR | -66.27% |
2022 Q1 | -11.25 Billion IDR | -10.01% |
2022 Q4 | -15.97 Billion IDR | -9.04% |
2021 Q1 | 9.25 Billion IDR | 205.77% |
2021 FY | 14.09 Billion IDR | 188.88% |
2021 Q4 | -10.23 Billion IDR | -228.58% |
2021 Q3 | 7.95 Billion IDR | 11.82% |
2021 Q2 | 7.11 Billion IDR | -23.12% |
2020 Q1 | 880.08 Million IDR | -59.42% |
2020 FY | -15.86 Billion IDR | -282.86% |
2020 Q4 | -8.75 Billion IDR | -275.08% |
2020 Q3 | -2.33 Billion IDR | 58.77% |
2020 Q2 | -5.65 Billion IDR | -743.0% |
2019 Q2 | -870.28 Million IDR | 0.0% |
2019 Q1 | -870.28 Million IDR | 0.0% |
2019 FY | 8.67 Billion IDR | 349.18% |
2019 Q4 | 2.16 Billion IDR | -73.7% |
2019 Q3 | 8.24 Billion IDR | 1047.55% |
2018 FY | -3.48 Billion IDR | -510.79% |
2017 FY | 847.43 Million IDR | 584.25% |
2016 FY | -175 Million IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Bundamedik Tbk | 211.43 Billion IDR | 117.092% |
PT Medikaloka Hermina Tbk | 780.69 Billion IDR | 104.629% |
PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | 102.994% |
PT Murni Sadar Tbk | 15.2 Billion IDR | 337.661% |
PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | 117.679% |
PT Royal Prima Tbk | -4.62 Billion IDR | -681.877% |
PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | 222.515% |
PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | 176.36% |
PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 102.091% |
PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | 134.009% |